We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Electronic Capsule Technology the Basis for Innovations in Personalized Medicine for Women

By LabMedica International staff writers
Posted on 30 Jan 2013
Two European biomedical companies have agreed to collaborate on the development of personalized diagnostic and therapeutic products in the area of women’s health.

Medimetrics BV (Heilbronn, Germany) and the newly formed LiGalli (The Hague, the Netherlands) will be pooling their expertise to develop and produce medical drug delivery and monitoring devices based on Medimetrics' IntelliCap electronic capsule. More...


The IntelliCap electronic capsule is a unique ingestible device that combines five technologies: electronically controlled drug release, laboratory measurement capability, GI tract navigation in the body, two-way real time communication, and the novel operating system. The capsule contains a fluid reservoir and a micro-fluidic pump capable of pumping fluids, pastes, or suspensions. Operation of the pump is controlled by an integrated microprocessor. The IntelliCap also contains sensors that measure the pH and temperature of the pill’s local environment and an ultralow power radio transceiver that allows two-way communication to a data-monitoring/control unit. It is powered by an on-board battery and its electronics are fully sealed to ensure biocompatibility.

LiGalli will contribute its in-depth experience in pharmaceutical and gynecological products to the partnership.

Dr.Willem de Laat, founder of LiGalli said, “This is a significant, but also a logical, step forward in the move towards personalized medicine, improving the diagnostic and therapeutic tools available to patients. Having access to this groundbreaking technology opens the door to developing individualized therapies, which for the first time could meet a woman’s specific needs. It then becomes possible to perform continuous diagnosis monitoring or time exactly when a therapy was delivered, adapt the quantity, and even interrupt the schedule, if necessary.”

Dr. Olaf Weiner, CEO of Medimetrics, said, “The new collaboration adds an exciting dimension within the area of women’s health, creating new and improved therapeutic opportunities for patients. More and more companies are recognizing the potential of our IntelliCap technology, seeking to capitalize on its diagnostic and drug delivery functionalities. It is already widely used by the pharmaceutical industry to rationalize and speed up the development of modified release formulations and dosage forms. By tailoring drug delivery in this way, it is also possible for patients to take their medication less frequently without compromising on efficacy.”

Related Links:
Medimetrics B.V.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
All-in-One Molecular System
AIO M160
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.